Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
23m agoSM Group raises renewable energy sourcing to 31% in 2025
23m agoMedtronic Singapore partners with Society of Colorectal Surgeons to strengthen surgical training
46m agoIndia’s Adani Power agrees JPVL and Churk acquisitions
1h agoOasis Proposes Truly Independent Outside Director Candidate for Comsys AGM to Accelerate Growth and Improve Corporate Governance (Securities Code: 1721 JT)
1h agoOasis Proposes Truly Independent Outside Director Candidate for Mirait AGM to Accelerate Business Growth and Improve Corporate Governance (Securities Code: 1417 JT)
Newcelx Ltd. logo

Newcelx Ltd.

About

3.16USD-0.02 -0.63%
Closed • Updated at 00:56 GMT+00:00
Market Cap$16.89M
Volume11.6K
Beta2.66
RSI48.01
Health TechnologyBiotechnology

Newcelx Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 30 2026
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026
Apr 20 2026
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Apr 1 2026
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
Mar 9 2026
NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes
Feb 12 2026
NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy

Community Chat

Ask AI

Try asking
6ix6ix